Regional metabolic rates for glucose estimated using [18Flfluorodeoxyglucose positron-emission tomography were compared in 16 drug-free patients with Tourette's syndrome (TS) and 16 age-and sex-matched normal volunteers. Tourette's syndrome patients were characterized by decreased normalized metabolic rates in paralimbic and ventral prefrontal cortices, particularly in orbitofrontal, inferior insular, and parahippocampal regions. Similar decreases were observed in subcortical regions, including the ventral striatum (nucleus accumbenslventromedial caudate) and in the midbrain. Published by Elsevier Science Publishing Co., Inc.
These changes were more robust and occurred with greater frequency in the left hemisphere. They were associated with concomitant bilateral increases in metabolic activity the supplementary motor, lateral premotor, and Rolandic cortices. Effects of prior exposure to neuroactive drugs did not account for these findings. These results suggest that an altered relationship between limbic-related regions of the cortex and striatum and cortical regions involved in the initiation of movement may play a role in the pathogenesis of this illness. [Neuropsychopharmacology 9:277-291, 1993J Gilles de la Tourette's syndrome (TS) is a complex neu rologic disorder characterized by multiple motor and vocal tics, associated behavioral disturbances, and a chronic, fluctuating course. Although it is now clear that the disorder is genetically transmitted and is therefore likely to be associated with a structural or chemical di athesis, the brain mechanisms involved in the genera tion of symptoms have never been identi&ed.
Tourette's syndrome is unambiguously a disorder of motor function. The multiple tics that are the hall mark of the syndrome must certainly involve brain re gions that participate in the organization, initiation, and execution of movement. Nevertheless, the abnormal movements observed in, and experienced by, TS pa tients diff er from involuntary movements (choreoathe tosis, myoclonus, and dystonia) typically encountered in other hyperkinetic movement disorders (Lang 1991; Bliss 1980) . Both motor and vocal tics are commonly preceeded by an experience of motivational tension and their expression is often followed by a sense of satis faction or relief. The urge to tic is consciously experi enced by the patient, who can suppress symptoms for a variable period of time, but will inevitably yield to what he feels "driven" to do . Symptoms may be de scribed as alien or due to the operation of a "second will." The TS patient O. (Meige and Feindel 1907) , describes a prototypical tic: "I know I am its author, but that cannot prevent my becoming its victim."
For these reasons, it appears likely that the patho genesis of TS is not confmed exclusively to the motor domain. The generation of symptoms may addition ally involve brain regions associated with motivation and may reflect an abnormality of brain systems that are involved in the coupling of motivation and action specifIcally those which effect neural transmission from the limbic to the motor systems. Similarly, because the disorder is frequently associated with complex be havioral disturbances including obsessions and com pulsions (Towbin, 1988) , attentional diffi culties (Com ings and Comings, 1988) , irritability, impulsivity, and self-injurious behavior (Riddle et al. 1988) , and due to the presence of coprolalia in approximately half of all patients , the neuroanatomic sub strate underlying symptoms in TS probably involves limbic as well as motor mechanisms.
But what regions of the brain are involved? The re sponse of both motor and vocal tics to typical neurolep tic agents (Seignot 1961; Shapiro et al. 1973 ) and the demonstration of altered levels of homovanillic acid (HV A) in the cerebrospinal fluid (CSF) of some patients (Cohen et al. 1979; Singer et al. 1982) have suggested a primary role for the dopamine system in TS, perhaps involving increased sensitivity of dopamine receptors or postsynaptic mechanisms to which these receptors are coupled. However, models derived from pharmaco logic information in this fashion inevitably suffer from a lack of anatomic specifIcity. Electrophysiologic studies demonstrate only nonspecifIc and nonlocalizing abnor malities (Van de Wetering et al. 1985; Sweet et al. 1973) ; in spite of reports of histologic or biochemical altera tions in postmortem studies of TS brains (Balthasar 1956; Haber et al. 1986; Singer et al. 1990) , no unequiv ocal neuropathologic changes have yet been associated with the disorder. The pathogenesis of Tourette's syn drome remains nearly as obscure as when the illness was fIrst described more than a century ago (Gilles de la Tourette, 1885) .
Positron-emission tomography (PET), using [
F] _
fluoro-2-deoxy-O-glucose (FOG), is a well-established method of characterizing functional activity in the liv ing human brain , which may be of particular value in illnesses without clear pathophysio logic features such as TS. Regional glucose metabo lism -coupled to energy-requiring processes driven by NEUROPSYCHOPHARMACOLOGY 1993 -VOL. 9, NO.4 the synaptic activity of neurons-appears to be a reli able index of functional activity within the central ner vous system (Sokoloff 1992) . In this study, we compared regional patterns of glucose metabolism in 16 drug-free individuals with typical TS and 16 age-and sex-matched control subjects in an attempt to characterize the func tional neuroanatomy of this illness.
SUBJECTS AND METHODS

Subjects
Sixteen patients with TS, 14 males and two females, aged 33 ± 7 years (mean ± SO; range 23 to 49 year s) consented to participate in this study after providing informed consent. Fourteen patients were right handed and two, one male and one female, were left handed. The diagnosis of TS was conflrmed by history and phys ical examination that excluded concurrent neurologi cal, medical or unrelated psychiatric illnesses, and con formed to OSM-III-R criteria.
All patients were drug free at the time of scanning. Four patients had been taking dopamine receptor an tagonists (haloperidol in three cases, pimozide in one) which were withdrawn at least 2 weeks (range 2 to 8 weeks) prior to the PET studies. Neuroleptics had been administered alone in two cases and in combination with other neuroactive medications (clonidine or im ipramine) in two others. Two additional patients had been receiving nonneuroleptic medications alone, which were similarly withdrawn (in one patient clonidine was discontinued 4 weeks prior to the studies, and in an other patient, verapamil was discontinued 2 weeks prior to the studies).
Nine additional patients had a history of exposure to neuroleptic (haloperidol or chlorpromazine) or non neuroleptic drugs (clonodine, imipramine or tranyl cypromine) but had not received treatment for at least 1 year prior to these studies. One patient had never been exposed to neuroactive medications .
Sixteen normal volunteers, 11 males and fIve fe males, aged 34 ± 10 years (mean ± SO; range 20 to 50 years) gave informed consent prior to participation. Fif teen subjects were right handed and one, a male, was left handed. Normal volunteers were without signifI cant abnormalities at the time of general physical and neurologic examination and histories were negative for neurologic, medical, or psychiatric illness. No control subject used prescription or nonprescription drugs within the 2 weeks prior to scanning.
PET Scans
Positron-emission tomography scans were performed on the NeuroPET (Brooks et al. 1980 ), a seven-slice positron tomograph with an in-plane resolution of 6 mm to 7 mm and an axial resolution of 11 mm to 12 mm FWHM. Subjects were seated in a modifted dental chair in a room with low ambient light and noise and allowed to acclimate to these surroundings. Eyes were patched and ears occluded before positioning the head within the scanner gantry. The plane of scanning was parallel to the canthomeatal line.
Over a period of 1 minute, 5 mCi of FDG was in jected intravenously, and 10-minute scans were initi ated 30 to 45 minutes after infusion. Between each scan, the position of the patient's head was shifted within the gantry to extend the anatomic range sampled. Up to five interleaved scans were performed in each ses sion, resulting in up to 35 slices per study. Arterialized venous blood ) was sampled through out the duration of the study, from the arm opposite the site of FDG infusion, to provide measurements of plasma FDG and glucose concentration over time. Pa tients were asked to remain still during the course of the procedure. Although they were not explicitly in structed to suppress symptoms, vocal or motor tics were rarely observed during the period of FDG uptake.
Local cerebral metabolic rates for glucose were cal culated according to the method of Brooks (1982) , utiliz ing an equation that is relatively insensitive to errors in rate constants and that incorporates a term for glu cose 6-phosphate dephosphorylation. A calculated at tenuation correction was performed using a visually fI tted outline of the scalp routinely apparent in the im ages. Scanner and gamma well counter were cross calibrated using a phantom containing a solution of [18F]fluoride.
Image Analysis
The results of PET studies are not infrequently incon sistent or difficult to replicate. This can be due to small patient numbers, differences in PET instrumentation or differences in the methods of data analysis. To mini mize the last source of error and to enhance the relia bility of our results, two technically distinct analytic ap proaches were applied to the PET data by separate investigators working independently, and the results of these analyses were compared.
Eight image planes (Figs. 1 and 2) were selected for analysis on the basis of recognizable cerebral landmarks identified in standard anatomic atlases (Damasio and Damasio 1989; Matsui and Hirano 1978; Duvernoy 1991) . Each investigator, blinded to diagnosis as well as to the other's results, selected planes of section and employed distinct technical strategies for regional seg mentation and estimation of glucose metabolic rates. of metabolic data. Cortical-CSF and cortical-white mat ter boundaries were defined using thresholding tech niques that located these edges at pixels with values of approximately 50% of the local cortical maximum. The segmented cortical mantle was then divided using a radial template that was adjusted with reference to major cortical landmarks (Fig. 3a) . Regional perimeters were reduced by one pixel to decrease in-plane partial volume averaging and overlap between contiguous regions. These irr egular cortical ROIs typically enclosed an area of between 25 and 75 pixels (100 to 300 rnm2).
Circular ROIs, ranging in area from 8 to 12 pixels (32 to 48 rnm2) depending upon the size of the anatomic area sampled, were applied to subcortical structures (basal ganglia, brainstem, and thalamus) and cortical regions (e.g., insula, medial temporal, and calcarine cor tices) in which anatomic detail was less precise. Data reduction was performed in these instances by averag ing values for structures within an image plane in which more than one small circular ROI was applied. This pro cess yielded 164 ROIs in all-82 in each hemisphere an average of approximately 20 per slice. In addition, brain size for each subject was estimated by averaging the cross-sectional areas of PET slices selected for use in analysis 1.
Analysis 2. Regional metabolic rates were obtained by placing small circular ROIs on each image plane. These regions were of a uniform size (12 pixels, 48 mm2) and were clustered into a series of templates that were in teractively adjusted to fit each subject's scan (Fig. 3b) . Following application and coarse adjustment, the ROIs were independently translated and placed over the lo cal maximum (activity peak) to decrease the effects of partial volume averaging . Suc cessive ROls were positioned no closer than within two pixels (4 mm) of the neighboring region, and local ac tivity was similarly maximized. Two hundred forty six such ROls were placed on the eight planes of section. Data reduction was performed by averaging values to yield estimated metabolic rates for somewhat larger, yet anatomically discrete regions. This process reduced the number of regions to 112: 56 in each hemisphere, an average of 14 per slice.
Although the total number of regions in analyses 1 and 2 differed, templates were designed such that regions corresponded to coded areas in a cornmon atlas (Damasio and Damasio (1989) , which assigns both func tional and cytoarchitectonic descriptors to anatomic areas of interest) for purposes of comparison.
Statistical Analysis
Both normalized and absolute metabolic rates were ana lyzed by univariate repeated-measures analyses of variance (ANOVA)-with diagnosis as the grouping
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RESULTS
Comparison of Normalized Metabolic
Rates in Patients and Controls Table 1 summarizes the results of overall repeated measures ANOV As performed on normalized metabolic rates in analyses 1 and 2. In both cases, the diagnosis by region interaction term was signmcant (p < .0001, either instance) indicating that TS patients and control subjects can be distinguished by a pattern of differences in metabolic activity in specmc regions of the brain.
These regions were identmed by comparing meta bolic rates in individual regions of interest. Figure 5 summarizes the group differences in normalized re gional values derived in analysis 1, and table 2 contains values derived in analysis 2. In both cases, signmcant differences between patients and controls are indicated by asterisks.
Of the 32 signifIcant differences detected in analy sis 1, and the 35 detected in analysis 2, 44 (22 pairs) were congruent: that is, diff erences, equal in sign, were iden tmed within the same regions in both analyses. Differ ences that attained statistical signifIcance in one analy sis only were accompanied by matching trends (p < .2) in the other analysis 70% of the time (16 of 23 remain ing cases), and signifIcant differences were commonly detected, in the other analysis, in contiguous, function ally related, or homologous contralateral ROIs. Never theless, as outlined above, only signmcant differences that were identmed in the same regions in both analy ses were considered reliable, that is, robust enough to potentially represent genuine differences between pa tients and controls. These regions are listed in Table 3 . In this table, differences located in two anatomically contiguous, functionally related regions (e.g., superior lateral premotor cortex 1 and 2) are grouped together as are right and left hemispheral ROIs. These reliable or congruent changes can be sum marized as follows. Tourette's syndrome patients, in the present study, appear to be characterized by lower relative metabolic rates in inferior, limbic-associated areas of the brain-in paralimbic and ventral prefron tal regions, in the striatum and the brainstem -and by higher relative metabolic rates in superior, sensorimo tor cortices.
In the inferior prefrontal and paralimbic regions of the cortex, decreased metabolic rates are observed in orbitofrontal, but not dorsolateral prefrontal cortices; patients are characterized by reductions in metabolic activity in the inferior paralimbic regions of the insula and in the related caudal orbital, but not cingulate cor tices. Decreases in metabolic activity are observed in the parahippocampal (entorhinal) region as well. In the basal ganglia, decreased metabolic activity in TS pa tients is most pronounced in the limbic-associated re gi on of the ventral striatum. This region of interest, at the z-axis resolution of our scanner, will include meta bolic information from the ventral striatum proper (nu cleus accumbens) and ventromedial regions of the cau date nucleus. Metabolic activity is decreased in the left anterior putamen in patients as well, but this diff erence is not as robust as that observed in the ventral stria tum. SignifIcant decreases in metabolic activity are also observed in the midbrain. In the superior sensorimo tor cortices, signifIcant increases in metabolic rates for glucose in TS patients are clustered in the frontal mo tor cortices-including supplementary motor, lateral premotor, and Rolandic regions.
There appears, in addition, to be a hemispheral asymmetry in the distribution of decreased metabolic rates: signifIcant decreases are more frequent, or more robust, in prefrontal, limbic, and striatal regions of the left hemisphere (X? = 10.32, p < .005, analysis 1; X? = 9.33, p < .005, analysis 2). The increases in normalized cerebral metabolic rates for glucose (CMRglu) in dorsal sensorimotor ROIs, on the other hand, are not signifI cantly lateralized.
All of these relative differences are depicted in Fig  ure 5 . Metabolic activity in inferior prefrontal cortices, striatum and brainstem of an individual TS patient and control are compared in Figure 6 . 
Discriminant Analyses
To determine whether or not cerebral metabolism in this circumscribed set of regions is sufficient to ac curately predict diagnosis, two-group discriminant analyses were performed. A separate analysis was con ducted for each data set, but only regional values that attained statistical signifIcance in both analyses were entered as discriminating variables.
Discriminant functions derived using this set of re gional metabolic rates were used to reclassify the origi nal set of cases to determine how often the correct di agnosis would be assigned. In both cases, metabolic rates in the limited, "reliable" set of regions assigned each subject to the correct diagnostic category without error. This indicates that metabolic rates in only those subcortical, ventral limbic, premotor, and Rolandic regions listed in Table 3 are needed to characterize TS patients and reliably distinguish them from normal con trols.
Comparison of Absolute Metabolic Rates in Patients and Controls
When absolute metabolic rates for glucose are com pared, analyses 1 and 2 appear to be sensitive to changes occurring at opposite ends of the metabolic spectrum. In either analysis, when mean global grey matter meta bolic rates were compared, no signifIcant differences between patients and normal volunteers were observed (analysis 1: TS = 8.46 ± 1.29 mg glucose/l00 g/min, normals = 8.69 ± 1.45; analysis 2: TS = 8.72 ± 1.28 mg glucose/l00 g/min, normals = 8.54 ± 1.32).
Nevertheless, repeated-measures ANOV As utiliz ing absolute regional metabolic rates generated a signifIcant diagnosis by region interaction term in both instances (analysis 1: F = 1.30; dt = 1,163; p < .007; anal ysis 2: F = 1.96; dt = 1,111; p < .0001), indicating that although global grey matter metabolic rates do not differ, TS patients and controls can again be distin guished by a pattern of differences in metabolic activ ity in specifIc regions of the brain. These brain regions were identifIed by comparing individual regional CMRglu values by univariate ANOV A. Regions in which diff erences (p < .05, uncorrected) were observed appeared to cluster in different areas of the brain, de pending on the analytic method used.
Analysis 1 appeared to be more sensitive in the de tection of decreased absolute regional metabolic rates in TS patients. Decreases in absolute CMRgiu were ob served in inferior limbic cortical and subcortical ROIs (left and right medial orbital, right caudal orbital, and left lateral orbitofrontal cortices; left inferior insular cor tex; and left and right parahippocampal regions; and left and right midbrain).
Analysis 2, on the other hand, appeared to be more sensitive in the detection of increased absolute Figure 5 . A representation of regional differences between normalized metabolic rates computed for TS patients and nor mal volunteers in analysis 1. Blue indicates a decrease in regional metabolism in TS patients, and red indicates an increase.
The magnitude of the differences between group means is indicated by the degree of stippling: changes of 2% to 4% are indicated by light stippling; 4% to 7% by moderate stippling; 7% to 10% by dense stippling; and greater than 10% by solid color. SignifIcant differences are indicated by asterisks: * p < .05, ** P < .01, *** P < .005, and **** p < .0001. Regions are identifIed by referring to Figure 4 . Figure 6 . Positron-emission tomography data, corresponding to image plane 3 (see figs. 1, 2, 4, and 5), from a TS patient Oeft) and a normal volunteer (right). Images represent normalized metabolic rates and were produced by dividing each pixel by the subject's global, whole-brain gray matter metabolic rate, calculated as outlined in the Methods section. Relative decreases in metabolic activity, which were signifIcant when the entire cohort of patients and controls were evaluated, can be seen in the ventral striatum, inferior insula and orbitofrontal cortices, particularly in the left hemisphere, and in the midbrain. Coefficients of variation for absolute regional meta bolic rates did not differ significantly between analy ses 1 and 2. In every case, significant differences de tected in one analysis were accompanied by matching trends in the other.
The differing sensitivities of analyses 1 and 2 may be related to methodologic variations and perhaps reflect diff erences in the effective sample space applied in each analysis. For example, whereas the technique employed in analysis 1 utilizes all of the data in the PET images (see Fig. 3 ), in-plane partial volume averaging will have a larger effect on estimated metabolic rates, that is, will result in more statistical bias. On the other hand, although analysis 2 utilizes a method that is de signed to minimize in-plane partial volume averaging ) and produces results that are more stable, it samples only a relatively small extent of the anatomic area in question. In any case, as outlined above, when metabolic rates are normalized, control ling for intersubject diff erences in CMRglu and thereby reducing group variances, the results of analyses 1 and 2 converge.
Effects of Drug Treatment in TS Patients
The potential effect of recent exposure to neuroactive medications in TS patients was evaluated. Patients were grouped according to drug history: subjects who had NEUROPSYCHOPHARMACOLOGY 1993-VOL. 9, NO.4 undergone acute withdrawal from medications (2 to 8 weeks prior to study; n = 6) were compared with those that had been drug-free for a year or more or who had never received neuroactive medications (n = 10). The effect of acute withdrawal from dopamine receptor an tagonists (n = 4) was tested independently.
When withdrawal from medications per se was ex amined, an effect on whole-brain metabolic rates for glu cose was apparent. Patients recently withdrawn from neuroactive drugs tended to have lower global meta bolic rates, and, this difference, in one instance, attained statistical signifIcance. (Analysis 1: 2-to 8-week drug free interval, global CMRglu = 7.64 ± .32 mg glu cose/l00 gmin; >1 year = 8. 95 ± 1.42; p = .045. Analy sis 2: 2-to 8-w e ek drug-free interval = 7.98 ± .34; >1 year = 9.17 ± 1.43; p = .07.) Although metabolic rates did not differ significantly when withdrawal from dopamine receptor antagonists was evaluated indepen dently, these trends persisted.
Therefore, to control for the potentially confound ing effects of drug history, regional metabolic rates in TS patients and controls were compared after subjects who had been withdrawn from medications 2 to 8 weeks prior to the study were removed from the anal ysis. Normalized regional metabolic rates in which significant group differences had previously been de tected in both analyses were reevaluated to determine whether differences that had been attributed to diag nosis would persist.
In all but a single instance, diff erences previously detected between patients and controls were again ob served. In analysis 1, only decreases in metabolism in the left anterior putamen in TS patients failed to attain statistical significance (p < .09). In analysis 2, all previ ously detected regional diff erences persisted when sub jects withdrawn from neuroactive medications were ex cluded. These results suggest that although recent exposure to neuroactive agents may have a global effect on metabolic rates for glucose, such an effect is not responsible for differences attributed to diagnosis in the present analysis.
Estimates of Brain Size and Effects of Gender
Brain size was estimated by calculating the average cross-sectional area of the image planes selected in anal ysis 1, excluding the top-and bottom-most slices in each instance to minimize partial volume averaging in the axial plane. There were no significant diff erences be tween patients and controls: TS, average cross-sectional area = 100.18 ± 6.97 cm2, normals = 100.35 ± 6.59 cm2• There were no signifIcant differences between average grey matter metabolic rates for glucose calcu lated for men and women in either analysis (analysis 1: males = 8.63 ± 1.38 mg glucose/l00 g/min, females = 8.64 ± .97; analysis 2: males = 8.47 ± 1.33, females = 8.95 ± 1.49). Repeated-measures ANOV A performed on values derived from both analyses yielded no sig niflcant effects of sex or signifIcant sex by region inter actions.
DISCUSSION
This work attempts to generate, in an exploratory fash ion, testable hypotheses regarding the functional neu roanatomy of Tourette's syndrome. Any conclusions drawn from these analyses must be considered prelim inary. Our results indicate, nevertheless, that signif1cant diff erences in regional CMRglu may in fact differenti ate TS patients from control subjects. The results of two ana lyses, each based upon a diff erent technical strategy, suggest that the pathogenesis of this illness may be as sociated with both increases and decreases in metabolic activity in speciflc regions of the brain. This pattern sug gests, in tum, a neuroanatomic model that could ac count for the generation of symptoms in this disorder.
In both analyses, decreases in normalized metabolic rates for glucose were detected in ventral limbic associated regions of the cortex (caudal and lateral or bitofrontal, insular and parahippocampal cortices) and in subcortical regions including the basal ganglia (par ticularly the ventral striatum, i.e., nucleus accumbens and ventromedial caudate) and the midbrain. These decreases were more robust in the left hemisphere. They appear to be associated with increases in normal ized metabolic rates in dorsal sensorimotor regions of the brain, including the supplementary motor area, lateral premotor, and Rolandic cortices. The increases in metabolic activity in these regions were more con sistently bilateral. Discriminant analyses suggest that metabolic rates in only this limited set of regions are needed to reliably distinguish TS patients from normal controls.
The reciprocal nature of the differences observed in superior and inferior regions of interest could con ceivably represent artifacts of the normcilization process itself. Nevertheless, the fact that both sets of changes were detected in either analysis 1 or 2 when absolute metabolic rates were compared suggests that these differences are real.
Differences between TS patients and controls that we observed are not likely to have resulted from com mon confounding variables such as age, sex, or brain size: estimates of brain size did not differ between pa tients and controls. The mean, standard deviation, and range of ages in patient and control groups were es sentially identical. Although the control group included slightly more females than did the TS patient group, no difference in CMRglu due to sex was detected in ei ther analysis.
Although we cannot entirely rule out the possibil- ity that metabolic changes observed in TS patients could, at least in part, represent the residual effects of chronic dopamine blockade or exposure to other neu roactive medications, the reevaluation of group differ ences with drug histories taken into account argues against this. Regional differences that were initially de tected between patients and controls persisted when subjects who had recently been withdrawn from medi cations (2 to 8 weeks prior to scanning) were excluded from the analysis, leaving only subjects who had been medication-free for a year or longer. This suggests that the effects of recent «1 year) exposure to neuroactive drugs cannot account for the differences attributed to diagnosis in this study. Finally, it is not likely that the changes we observed represent the metabolic correlates of motor activity ex pressed during the scanning procedure. As outlined above, although patients were instructed to remain still during the course of the procedure and were not ex plicitly instructed to suppress symptoms, vocal or mo tor tics were only rarely observed during the period of FOG uptake. This seemingly paradoxical decrease in symptoms is not uncommon in TS patients under struc tured conditions -in a physician's office or classroom and may reflect automatic or unintentional tic suppres sion. Thus, the present fIndings could conceivably reflect metabolic changes related to the inhibition of ab normal movements rather than abnormal motor activ ity per se.
Relationship to Other Functional Neuroimaging Studies
The present results confIrm a preliminary report (Chase et al. 1986 ) that identifIed decreases in regional cere bral metabolism in TS patients in caudal, medial, and lateral orbitofrontal cortices, and inferior insula and ven tral regions of the basal ganglia. These data were tenta tively interpreted as suggesting that striatal and corti cal areas associated with the limbic system might be involved in the pathogenesis of TS, a conclusion that is supported and extended by the present fIndings. Baxter and Guze (1993) have presented results that appear to differ slightly from our own. These authors report that patients with the concurrent diagnoses of TS and obsessive-compulsive disorder (OCD) showed increased glucose utilization in the putamen when com pared to patients with a diagnosis of OCD alone (n = 10; either case) and that all patients with obsessive compulsive symptoms, whether tics were present or not, had elevated orbitofrontal metabolic rates for glu cose when compared to controls. Any differences be tween these results and our own could be due to the nature of the comparisons, differences in sample size, age, sex, severity of illness, as well as differences in re gion placement or other methodologic variables. More to the point, perhaps, the relationships between cere bral metabolism and obsessive-compulsive symptoms or other complex behavioral features associated with TS have not been addressed in the present study and will be reported in a separate communication (Braun et al. in preparation) .
The present fmdings, however, are by and large consistent with technitium-Iabeled hexamethyl-propyl ene amine oxide SPECT studies of regional cerebral blood flow in TS. Riddle et al. (1992) report regional decreases in cerebral perfusion in inferior frontal cor tices and lenticular nuclei in nine TS patients (vs. nine normal controls) that appear to be more pronounced in the left hemisphere . Hall et al. (1990) detected hypoperfusion in frontal lobes, mesial temporal struc tures, and basal ganglia in 25 TS patients using HMPAO. These abnormalities were reported as being frequently asymmetric, although no systematic later alization is reported. George et al. (1993) evaluated ce rebral perfusion with HMP AO in 10 TS patients with and 10 without obsessive-compulsive symptoms, and found increased right frontal/visual cortical activity when the entire cohort of patients was compared to con trols (n = 8); the frontal region of interest in this study (placed at the level of the basal ganglia) may have in cluded information from both prefrontal and frontal mo tor cortices.
It is interesting to note that several of the brain regions that appear to be affected in TS patients have been implicated in PET studies of two related illnesses OCD and attention de&cit hyperactivity disorder (ADHD). In each instance, however, the direction of these changes (vs. regional control values) is different than that which we observed in TS patients. Obsessive compulsive disorder appears to be associated with in creased metabolic rates in the orbitofrontal cortices and basal ganglia (Baxter et al. 1987; Nordahl et al. 1989; Swedo et al. 1989) , and ADHD is associated with decreases in superior sensorimotor structures, centered in the premotor cortices (Zametkin et al. 1990) .
It is possible that the same general brain regions are involved in all three of these illnesses, but that the functional interplay between them may differ, account ing for manifest diff erences in the associated clinical symptoms. Obsessive compulsive disorder and TS, for example, might in some ways be considered antitheti cal conditions, characterized by motor constraint and discharge, respectively (Cohen et al. 1982) . These clin ical distinctions could conceivably be related to the respective increases or decreases in orbitofrontal me tabolism with which the disorders appear to be as sociated. In a very simplistic fashion, if the same set of brain regions were to constitute a network involved in a genetic diathesis, differences in the dynamic rela tionship between these regions might account for the variations in phenotypic expression. NEUROPSYCHOPHARMACOLOGY 1993-VOL. 9, NO. 4 Functional Characteristics of Identified
Regions of Interest
The brain regions in which cerebral metabolic rates differentiate TS patients and controls appear to repre sent a heterogeneous collection of structures. They are nevertheless functionally related to one another in a way that supports a tentative model of brain dysfunc tion in TS. The relationship between these regions may normally subserve limbic regulation of motor function.
The superior cortical -premotor and Rolandic ROIs in which metabolic rates are increased in TS pa tients are clearly involved in the direct regulation of somatomotor activity, the Rolandic regions mediating supraspinal influences on lower motor neurons in the brainstem and spinal cord (BrodaI 1981) , and the sup plementary motor and lateral premotor cortices in volved in associative or integrative functions related to the organization and initiation of complex sequences of movements (Brodal 1981; Fried et al. 1991) .
Activity in the premotor cortices is in turn regulated by projections from a variety of cortical and subcortical brain regions. Increased metabolic rates in the frontal motor regions in TS patients in our study are associated with decreases in glucose utilization in an array of ven tral regions of the cortex. These inferior cortical areas are in fact constituents of an identmed brain system: paralimbic cortices and limbic-related regions of the ven tral prefrontal cortex. These regions are in fact derived from a specifIc subdivision of the paralimbic belt, a paleo cortical or "olfactocentric" system centered on the insula (Sanides 1972; Goldberg 1985; Pandya and Barnes 1987) .
Paralimbic regions, in general, are interposed be tween sensorimotor and limbic areas of the brain and may serve as "a synaptic buffer between external real ity and internal urges" analogous, in computing terms, to "and/or gates interposed between input and output channels ... allowing the organism to trigger or inhibit behavior" (Mesulam 1985) . The paralimbic and inferior prefrontal regions may be involved in monitoring on going limbic input to permit impulses to be regulated in accordance with appropriate social norms. (Cum mings, 1985) .
Paralimbic regions intersect with motor pathways through a variety of routes (Pandya and Yeterian 1985; Mesulam and Mufson 1985; Witter et al. 1989) . Never theless, the orbital, insular, and mesial temporal cor tices are in a position to affect motor function most directly via their monosynaptic projections to the basal ganglia (Heimer and Wilson 1975; DeLong 1983; Alex ander et al. 1986) , nuclei that play a pivotal role in regulating inhibitory tone in the motor cortices (Cheva lier and Deniau 1990) . It is to the ventral portion of the striatum that these regions project.
The ventral striatum represents the "limbic-motor interface" (Stevens 1973 ; Scheel-Kruger and Wilner 1991). It is the principal site in which information from limbic structures gains access to the motor system (Mogenson 1987; Heimer et al. 1982) in part via inter actions with dorsal elements of the core nuclei of the basal ganglia (Haber et al. 1985 (Haber et al. , 1990 . If functional changes in paralimbic regions are linked to changes in the frontal motor cortices in the TS brain, projections through the ventral striatum may be the most direct route through which such coupling might occur. All of these regions may additionally represent elements of one or more of the parallel corticostriatal-thalamo cortical circuits proposed by Alexander and coworkers (1986) . This issue will be addressed in a separate com munication (Braun et al. in preparation) .
The involvement of the midbrain is somewhat more diffi cult to interpret given the functional heterogene ity of this structure and the limited resolution of the PET technique itself. Nevertheless, the midbrain is a critical point of intersection for both limbic and motor systems, and the suggestions that this region may be involved in the pathogenesis of TS has been advanced previously (Oevinsky 1983) . All of these hypotheses need to be rigorously tested.
Further studies aimed not at imaging limbic and motor activity in TS patients at rest, but during the execution of normal and abnormal movements, will help to sup port, extend, or modify the present conclusions.
